GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said in a BSE filing.

New Delhi: GlaxoSmithKline Consumer Healthcare on August 1 reported a 23.76 per cent rise in net profit to Rs 248.08 crore for the quarter ended June 2019.

The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said in a BSE filing.

Also Read: Pfizer, GSK consumer healthcare venture to focus on China, US market

Total income stood at Rs 1,320.90 crore for the quarter under consideration as against Rs 1,203.59 crore for the same period a year ago.

GlaxoSmithKline plc (GSK), a British multinational pharmaceutical company was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. GSK's consumer healthcare division, which earned £5.2 billion in 2013, sells oral healthcare, including Aquafresh, Maclean's and Sensodyne toothpaste and drinks such as Horlicks, Boost and a chocolate-flavoured malt drink sold in India.

Also Read: GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore